Olaparib
Olaparib is a compound that functions as a poly(ADP-ribose) polymerase (PARP) inhibitor, used in pharmaceutical manufacturing. It is a member of the N-acylpiperazine class and is employed as an antineoplastic agent, specifically as an apoptosis inducer via inhibition of NAD(+) ADP-ribosyltransferase.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 763113-22-0
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
4-{[4-fluoro-3-(piperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate for olaparib synthesis
4-{[4-fluoro-3-(4-nitrosopiperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
nitrosamine impurity reference standard
DL-Methamphetamine
active pharmaceutical ingredient
2,4-Quinazolinediamine, N2-(3-aminopropyl)-6,7-dimethoxy-N2-methyl-
alfuzosin related substance impurity
Enalaprilat
active pharmaceutical ingredient
N-((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-L-proline
active pharmaceutical ingredient
4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
FDLYAMZZIXQODN-UHFFFAOYSA-N
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F